Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma
about
The clinicopathological and gene expression patterns associated with ulceration of primary melanomaFrontiers of cancer care in Asia-Pacific region: cancer care in AustraliaIRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.New Perspectives of "omics" Applications in Melanoma Research.1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.Enhancement of dendritic cells as vaccines for cancerThe anticancer immune response: indispensable for therapeutic success?Immune cell profile of sentinel lymph nodes in patients with malignant melanoma - FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcomeThe Janus face of dendritic cells in cancer.Biomarkers in melanoma.Unravelling the complexity of cancer-immune system interplay.Tumor-altered dendritic cell function: implications for anti-tumor immunity.Adjuvant therapy for high-risk melanomaDendritic Cells in the Context of Human Tumors: Biology and Experimental Tools.Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma.The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinomaImmunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis.Is primary melanoma ulceration a factor of good response to adoptive immunotherapy?Autophagy and ATP-induced anti-apoptosis in antigen presenting cells (APC) follows the cytokine storm in patients after major trauma.Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Tumor Immuno-Environment in Cancer Progression and Therapy.Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).Molecular pathology of cutaneous melanoma
P2860
Q34772146-2CB73FD3-D789-4414-BECF-0C12587676A8Q34991701-8AFB9E6A-46A1-4906-811F-B364098A9A54Q35156105-954F117A-2A20-4246-A0CC-EF6E58FA6BE0Q35670683-66D24745-71C7-4499-8FDD-9D00E33BCCCBQ35915769-DC2F3973-07E4-4D96-BD99-06A36815BC86Q36209210-F3D2BBCF-0FE4-48CA-BB03-B06832D5DE96Q36677608-2F8B0FFD-D39C-4E94-93F3-9A3D4E411B8DQ36686432-CB0A9416-0AB9-4EBF-8F2E-4A34711072D1Q37287170-58C37594-D885-4D6D-A1F0-3615743F6652Q37555801-AB9E3B4A-E390-45AE-BF0E-9176F9A62A59Q37765590-C50BA779-2279-45A8-9362-DA5860F1504CQ38123166-65B4B657-F20D-43D8-990C-74E019830E47Q38555842-EF7322E8-3B70-4DD0-B5FD-EA594ACF81BBQ38786002-878572E4-F1E0-406B-8233-A6A36641D1F5Q39515361-CFC8E2FF-D5D2-4BB5-A9B1-1756AD5DFAFCQ39724884-646F19EA-F1CC-4DBB-B867-97E1BDF0F569Q40939669-7A0A7816-C074-4E2F-A319-77402EDA7E76Q42692005-ED9AB437-ACE1-4394-9A1F-47551249785AQ42727612-51C1BC1D-EA13-42BD-86E0-6DCE8F33DAB8Q43127268-FEDCB694-6B91-4C9C-B638-A4682749789FQ47135720-2C0C50B6-8386-4019-B120-41C332F5DA6FQ49592937-E6247F57-4276-4484-A65F-86F098E4C8D5Q51035013-DEFA2EF1-BC04-46EF-9691-508C3C3016D2Q56428911-0469464F-9294-41B7-9BE7-DD0E050DA903
P2860
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Long-term protective effect of ...... ining micrometastatic melanoma
@ast
Long-term protective effect of ...... ining micrometastatic melanoma
@en
Long-term protective effect of ...... ining micrometastatic melanoma
@nl
type
label
Long-term protective effect of ...... ining micrometastatic melanoma
@ast
Long-term protective effect of ...... ining micrometastatic melanoma
@en
Long-term protective effect of ...... ining micrometastatic melanoma
@nl
prefLabel
Long-term protective effect of ...... ining micrometastatic melanoma
@ast
Long-term protective effect of ...... ining micrometastatic melanoma
@en
Long-term protective effect of ...... ining micrometastatic melanoma
@nl
P2093
P50
P1476
Long-term protective effect of ...... ining micrometastatic melanoma
@en
P2093
Alain Spatz
Alexander Eggermont
Bruce Elliott
Caroline Robert
Danielle Lienard
Donata Rimoldi
Elena Musat
European Organization for Research and Treatment of Cancer Melanoma Group
John F Thompson
Martin Cook
P304
P356
10.1158/1078-0432.CCR-07-0358
P407
P577
2007-07-01T00:00:00Z